[Therapeutic experiences with oxazepam--a derivative of the benzodiazepine series--in child and adolescent psychiatry].
D000293:Adolescent; D000296:Adolescent Psychiatry; D000328:Adult; D000374:Aggression / Q000187:drug effects; D000639:Amitriptyline / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use*; D001925:Brain Damage, Chronic / Q000188:drug therapy; D001927:Brain Diseases / Q000188:drug therapy*; D002090:Butyrophenones / Q000627:therapeutic use; D002648:Child; D002665:Child Psychiatry; D002675:Child, Preschool; D002749:Chlorprothixene / Q000627:therapeutic use; D004569:Electroencephalography; D004775:Enuresis / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D005239:Fear / Q000187:drug effects; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008620:Meprobamate / Q000627:therapeutic use; D008728:Methotrimeprazine / Q000627:therapeutic use; D010076:Oxazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use; D011596:Psychomotor Disorders / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013315:Stress, Psychological / Q000188:drug therapy; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000927:Anticonvulsants; D002090:Butyrophenones; D010640:Phenothiazines; D014149:Tranquilizing Agents; D000639:Amitriptyline; D010076:Oxazepam; D008728:Methotrimeprazine; D008620:Meprobamate; D002749:Chlorprothixene; D013881:Thioridazine
Therapeutische Erfahrungen mit Oxazepam--einem Abkömmling der Benzodiazepin-Reihe--in der Kinder- und Jugendpsychiatrie.